Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.

SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Development of Sales/Annual Results SCHOTT Pharma delivers right after IPO with strong profitable growth for

December 20, 2023

Palbociclib Regimen Yields ‘Incredible’ PFS Gain in Metastatic Breast Cancer

SAN ANTONIO — The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy resulted in a significant and clinically meaningful improvement in progression-free

December 13, 2024

AbbVie drops Caribou partnership on gene-edited CAR-T therapy

AbbVie has terminated its collaboration with Caribou Biosciences to develop two off-the-shelf CAR-T therapies, Caribou disclosed Tuesday afternoon. AbbVie paid the Jennifer Doudna-founded startup $40

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.